Literature DB >> 28678327

LncRNA625 modulates prostate cancer cells proliferation and apoptosis through regulating the Wnt/β-catenin pathway by targeting miR-432.

J-B Li1, F Liu, B-P Zhang, W-K Bai, W Cheng, Y-H Zhang, L-J Yu.   

Abstract

OBJECTIVE: Prostate cancer (PCa) is the second leading contributor to male malignancy-associated death in developed countries. The study aimed to evaluate the effects of lncRNA625/miR-432 on the prostate cancer cells and the underlying molecular mechanism. PATIENTS AND METHODS: The cell proliferation was detected using the MTT and colony formation, and cells apoptosis and cell cycle were analyzed with the flow cytometry. Luciferase reporter assay was carried out to detect the correlation between miR-432 and TRIM29 and PYGO2. Besides, reverse transcription-PCR and Western blot were performed to detect the mRNA and protein levels in prostate tissues and PC3 cells.
RESULTS: lncRNA625 and miR-432 levels were consistently reduced in the PCa tissues compared with the healthy control and lncRNA625 levels significantly affect the miR-432 expression in PC3 cells, indicating that miR-432 is a direct target of lncRNA625. Besides, lncRNA625 overexpression could inhibit the cancer cells growth, arresting cell cycle progression at the G1/S phase, and significantly induce apoptosis of PC3 cells, but reversed by the miR-432 inhibitor. Most importantly, we further found that miR-432 could deactivate Wnt/β-catenin pathway via suppressing TRIM29 and PYGO2 directly.
CONCLUSIONS: lncRNA625 could functionally inhibit PC3 cells proliferation and promote cells apoptosis through regulating the Wnt/β-catenin pathway by targeting miR-432.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28678327

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.

Authors:  Shanzong Wang; Baohong Gao; Hailin Yang; Xuejian Liu; Xia Wu; Weijuan Wang
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

2.  Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827.

Authors:  Ming Hu; Mingliang Ren; Zhenhua Zhao; Xuejiang Cui; Ming Shi; Yunjie Yang; Haiyan Guo
Journal:  Oncol Lett       Date:  2022-06-27       Impact factor: 3.111

3.  MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.

Authors:  Dengkun Lv; Zhen Zhen; Defa Huang
Journal:  Exp Ther Med       Date:  2018-11-29       Impact factor: 2.447

4.  Circ_0132817 facilitates cell proliferation, migration, invasion and glycolysis by regulating the miR-432-5p/NOL4L axis in neuroblastoma.

Authors:  Yafei Fang; Yuqian Yao; Kangwei Mao; Yanyan Zhong; Yan Xu
Journal:  Exp Brain Res       Date:  2021-04-10       Impact factor: 1.972

Review 5.  Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Authors:  Jiangfeng Li; Haixiang Shen; Haiyun Xie; Yufan Ying; Ke Jin; Huaqing Yan; Song Wang; Mingjie Xu; Xiao Wang; Xin Xu; Liping Xie
Journal:  Cancer Manag Res       Date:  2019-01-15       Impact factor: 3.989

6.  Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.

Authors:  Yuan Yuan; Xiaogang Chen; Enying Huang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

7.  Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.

Authors:  Hongwei Chen; Yugang Chi; Mengyue Chen; Limei Zhao
Journal:  Cancer Manag Res       Date:  2021-02-12       Impact factor: 3.602

8.  A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.

Authors:  Jie Zhang; Chuanqin Xu; Yan Gao; Yi Wang; Zongli Ding; Yueming Zhang; Wenyi Shen; Yulong Zheng; Yufeng Wan
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

9.  LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer.

Authors:  Teng Li; Yi Xing; Fan Yang; Yangyang Sun; Shaojin Zhang; Qingwei Wang; Weixing Zhang
Journal:  Cancer Med       Date:  2020-04-05       Impact factor: 4.452

10.  MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma.

Authors:  Tingting Wang; Mingyu Du; Wenjun Zhang; Hui Bai; Li Yin; Wei Chen; Xia He; Qi Chen
Journal:  Onco Targets Ther       Date:  2019-12-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.